A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.
In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.
The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.
The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.
Regulations Take the Lead in Healthcare Restroom Design
AHN Allegheny Valley Hospital Opens Expanded Inpatient Rehabilitation Unit
HSHS and Lifepoint Rehabilitation Partner on New Inpatient Rehab Hospital in Green Bay
Turning Facility Data Into ROI: Where Healthcare Leaders Should Start
Sutter Health Breaks Ground on Advanced Cancer Center and Care Complex